KBC Securities - Pharvaris NV (PHVS) Pharvaris To present clinical data at the AAAAI 2026

Report

KBC Securities

Mathijs Geerts Danau

Pharvaris To present clinical data at the AAAAI 2026

Pharvaris will present multiple datasets at AAAAI 2026, including topline RAPIDe-3 results, final CHAPTER-1 data, supporting evidence for the extended-release formulation, AMRA endpoint validation, and results from a new kinin biomarker assay. We look forward to the prophylactic phase 3 (CHAPTER-3) readout in 3Q26 and reiterate our Buy and $ 36 TP.

11/02/2026 1 EN

Underlying

Pharvaris NV

See profile

NL00150005Y4 NASDAQ Stock Market Netherlands

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Mathijs Geerts Danau

Other Reports on these Companies

KBC Securities

Morning Notes : ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

: ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

February 11, 2026 February 11, 2026 1 EN

GlobeNewsWire

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting Pivotal Phase 3 data from RAPIDe-3 of deucrictibant for the on-demand treatment of HAE attacks to be presented for the first time ZUG, Switzerland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced the acceptance of six abstracts for p...

February 10, 2026 February 10, 2026 1 EN

Aedifica Feedback analyst call

Feedback analyst call

February 13, 2026 February 13, 2026 1 EN

Guy Sips ... (+5)

Guy Sips
Hilde Van Boxstael
Lynn Hautekeete
Thomas Couvreur
Wim Lewi

Morning Notes : AED BB, OPTI BB, HOMI BB, KIN BB, MONT BB

: AED BB, OPTI BB, HOMI BB, KIN BB, MONT BB

February 13, 2026 February 13, 2026 1 EN

Wim Lewi

Wim Lewi

Montea Good things come to those who wait (for the big boxes)

Yesterday, Montea reported results that had an initial negative market reaction. After the call, the management and chairman Dirk De Pauw were available for a sit-down lunch to give more colour. The Q&A session centered on the pace of the development pipeline. Montea removed its project table as it believes it hurts their negotiating capacity. Now, it just reports an expected GLA of 236k sqm that will be completed over the next 2 years. The reason why it takes longer to develop the landbank is also due to the selectivity of Montea to certain projects. It reserves its best plots for single tena...

February 13, 2026 February 13, 2026 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Pharvaris To present clinical data at the AAAAI 2026

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : ABN NA, AD NA, HEIA NA, LOTB BB, RAND NA, ALFEN NA, PHVS US

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Aedifica Feedback analyst call

Morning Notes : AED BB, OPTI BB, HOMI BB, KIN BB, MONT BB

Montea Good things come to those who wait (for the big boxes)

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe